FDA.reportPublic FDA data

NDC 50268-223-11 - Doxazosin

This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.

Product NDC
50268-223
Requested NDC
50268-223-11
Package NDCs from labels
50268-223-11, 50268-223-15
Manufacturer
AvPAK
Effective date
2026-03-24
Current FDA listing
Not matched in FDA.report NDC product tables

DailyMed Labels#

Label, Manufacturer, Effective date table
LabelManufacturerEffective dateType
Doxazosin - AvPAKAvPAK2026-03-24HUMAN PRESCRIPTION DRUG LABEL

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
50268-223-11Doxazosin1 in 1 BLISTER PACKTABLET13
50268-223-15Doxazosin50 in 1 BOXTABLET503

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
50268-223DOXAZOSIN TABLET [AVPAK]1Current NDC, Legacy NDC, 2 package rows20220510_de9ab9a4-d8b8-8b36-e053-2a95a90aaa35.zip

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
50268-223-11EA - Each50268-223d5458fb4-a8b6-44b2-9552-e2cd95fc684612022-06-06
50268-223-15EA - Each50268-223eb9edaae-5802-4a95-9b8e-b0c67b826fe312022-06-06

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 4 · 68 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
DoxazosinDOXAZOSINREMEDYREPACK INC.30a6bb83-f91b-4c4f-a849-4f2be3735a0e2026-08-14Warnings, Adverse reactionsExact identifier
application number: ANDA075580
rxcui: 197626
unii: 86P6PQK0MU
DoxazosinDOXAZOSINMajor Pharmaceuticals3354196f-bbcf-4bc5-94f6-e6e8e132acb12026-08-05Warnings, Adverse reactionsExact identifier
application number: ANDA075580
rxcui: 197625
rxcui: 197626
rxcui: 197627
unii: 86P6PQK0MU
DoxazosinDOXAZOSINA-S Medication Solutionsbfea0b5b-9354-490f-88ff-008134077d242026-07-16Warnings, Adverse reactionsExact identifier
application number: ANDA075580
rxcui: 197625
rxcui: 197628
rxcui: 197626
rxcui: 197627
unii: 86P6PQK0MU
DoxazosinDOXAZOSINREMEDYREPACK INC.71815e8f-33ed-4f36-a8ec-d4443151a9d82026-07-08Warnings, Adverse reactionsExact identifier
rxcui: 197626
unii: 86P6PQK0MU
DoxazosinDOXAZOSINGolden State Medical Supply, Inc.54eeef3d-c906-37e7-e063-6294a90afca22026-06-23Warnings, Adverse reactionsExact identifier
rxcui: 197625
rxcui: 197628
rxcui: 197626
rxcui: 197627
unii: 86P6PQK0MU
DoxazosinDOXAZOSINREMEDYREPACK INC.bf2f7b41-f14d-4fcd-8db3-f507ca6ff78b2026-06-12Warnings, Adverse reactionsExact identifier
application number: ANDA075580
rxcui: 197627
unii: 86P6PQK0MU
DoxazosinDOXAZOSINREMEDYREPACK INC.ec06f008-37a1-4757-a3ee-0b4720912bc42026-06-11Warnings, Adverse reactionsExact identifier
rxcui: 197626
unii: 86P6PQK0MU
DoxazosinDOXAZOSINPD-Rx Pharmaceuticals, Inc.2ea9bb6b-a4f0-496a-b27b-4454167a4b702026-05-13Warnings, Adverse reactionsExact identifier
application number: ANDA075580
rxcui: 197626
unii: 86P6PQK0MU
DoxazosinDOXAZOSINCardinal Health 107, LLC08521333-ff21-45ad-b99e-1f43d945d24d2026-04-24Warnings, Adverse reactionsExact identifier
application number: ANDA075580
rxcui: 197626
unii: 86P6PQK0MU
DoxazosinDOXAZOSIN MESYLATEBryant Ranch Prepack277c3278-4fe2-47ac-9115-15b417325ffd2026-04-13Warnings, Adverse reactionsExact identifier
rxcui: 197627
unii: 86P6PQK0MU
DoxazosinDOXAZOSINPreferred Pharmaceuticals Inc.2110eec5-949d-4718-ad6d-3629e5db8a072026-04-08Warnings, Adverse reactionsExact identifier
application number: ANDA075580
rxcui: 197627
unii: 86P6PQK0MU
DoxazosinDOXAZOSINPreferred Pharmaceuticals Inc.e046e0b7-f510-4318-9884-034d683864d42026-04-08Warnings, Adverse reactionsExact identifier
application number: ANDA075580
rxcui: 197626
unii: 86P6PQK0MU
DoxazosinDOXAZOSINAvPAKde9ab9a4-d8b8-8b36-e053-2a95a90aaa352026-03-24Warnings, Adverse reactionsExact identifier
application number: ANDA075580
ndc (package): 50268-222-11
ndc (package): 50268-225-11
ndc (package): 50268-225-15
ndc (package): 50268-223-11
ndc (package): 50268-224-15
ndc (package): 50268-222-15
ndc (package): 50268-223-15
ndc (package): 50268-224-11
ndc (product): 50268-223
ndc (product): 50268-224
ndc (product): 50268-222
ndc (product): 50268-225
ndc11 (package): 50268022311
rxcui: 197625
rxcui: 197628
rxcui: 197626
rxcui: 197627
spl id: 4dc6c398-ea92-808b-e063-6294a90ad2fc
spl set id: de9ab9a4-d8b8-8b36-e053-2a95a90aaa35
unii: 86P6PQK0MU
DoxazosinDOXAZOSINAvKAREe3d381c1-3b2f-af70-f4e6-08d6202eed252026-03-24Warnings, Adverse reactionsExact identifier
application number: ANDA075580
rxcui: 197628
rxcui: 197626
rxcui: 197627
unii: 86P6PQK0MU
DoxazosinDOXAZOSIN MESYLATEBryant Ranch Prepacke2f5d7d2-21aa-4921-8035-da945d3c565c2026-03-04Warnings, Adverse reactionsExact identifier
rxcui: 197627
unii: 86P6PQK0MU
DoxazosinDOXAZOSINNuCare Pharmaceuticals, Inc.54116886-ea5e-5320-e054-00144ff8d46c2026-02-16Warnings, Adverse reactionsExact identifier
application number: ANDA075580
rxcui: 197626
unii: 86P6PQK0MU
DoxazosinDOXAZOSIN MESYLATEBryant Ranch Prepack8641cdb1-dc16-4a13-8a84-bc8f6d58b4d42026-02-13Warnings, Adverse reactionsExact identifier
rxcui: 197626
unii: 86P6PQK0MU
DoxazosinDOXAZOSINBryant Ranch Prepack54549d19-6311-4dbb-8622-fd3e5440551a2026-01-29Warnings, Adverse reactionsExact identifier
application number: ANDA075580
rxcui: 197627
unii: 86P6PQK0MU
DoxazosinDOXAZOSINNorthwind Health Company, LLCf2b35586-d550-3fcb-e053-2995a90a34032026-01-19Warnings, Adverse reactionsExact identifier
rxcui: 197627
unii: 86P6PQK0MU
DoxazosinDOXAZOSIN MESYLATENorthwind Health Company, LLCf6c9856e-9154-f349-e053-6294a90a9f2c2026-01-19Warnings, Adverse reactionsExact identifier
rxcui: 197627
unii: 86P6PQK0MU

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.